Key takeaway
Across 31 randomized trials (1,403 children and adolescents), mind-body exercise, exergaming and multi-component physical activity were linked to moderate to substantial cognitive gains over usual care, while aerobic exercise showed no significant effect. Certainty of evidence was very low to low, so the rankings are tentative.
Study design
Trial meta-analysis
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Physical activity can improve cognition, but it is unclear which type works best for children and adolescents with neurodevelopmental disorders (NDDs) such as ADHD and autism spectrum disorder (ASD). The authors compared different types of physical activity on attention, memory and executive functions.
Who and how
Systematic review and frequentist network meta-analysis (which compares several interventions at once, directly and indirectly) of randomized controlled trials. Seven databases (Web of Science, PubMed, Medline, APA PsycINFO, Embase, CINAHL, SPORTDiscus) were searched from inception to September 2023. Trials enrolled children and adolescents aged 5-17 with a diagnosed NDD and compared physical activity with any non-drug treatment or control. Effects were standardized mean differences (SMD) from random-effects models, and dropout served as a measure of acceptability. Registered as PROSPERO CRD42023409606.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 131 trials (n = 1,403, mean age 10.0 ± 1.9 years; 66 arms) were included.
- 2Compared with usual care, mind-body exercise had SMD 1.91 for attention and 0.92 for executive functions; exergaming (active video games) had SMD 1.58 for attention, 0.97 for memory and 0.94 for executive functions; multi-component physical activity had SMD 0.79 for executive functions. Aerobic exercise had no significant effect.
- 3For executive functions, exergaming (SMD 0.78, 95% CI 0.12 to 1.45) and multi-component activity (SMD 0.64, 95% CI 0.11 to 1.18) beat aerobic exercise.
- 4Within specific conditions, exergaming lost its advantage over usual care for attention and memory in ADHD and for executive functions in ASD, whereas multi-component activity showed significant benefits across these domains and groups.
- 5Certainty of evidence was very low to low. Dropout did not differ significantly among mind-body exercise, exergaming and multi-component activity.
Limits & uncertainty
- 1Certainty of evidence was rated very low to low, so the large SMDs may overstate real benefits, especially from small trials.
- 2Many comparisons are indirect, and the authors themselves say more high-quality trials with direct head-to-head comparisons are needed.
- 3The results pool different NDDs, ages from 5 to 17 and many cognitive tests, and subgroup results for ADHD and ASD rest on fewer trials.
- 4This reading is based on the abstract only.
What to take from it
For a child with ADHD or autism, this suggests that varied, engaging activity (mind-body practices, active games, mixed training) may be worth trying alongside usual care, and that plain aerobic exercise was not shown to help cognition here. Because the evidence is weak, choices about therapy should be made with the child's care team.
Reading your own data
For a child, steps, active minutes and workout logs from a wearable can show how regularly they take part in an activity. They cannot measure attention or executive function, so compare activity patterns and school or clinic feedback over weeks, using the same device.
How to read this evidence
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Physical activity (PA) interventions have been shown to yield positive effects on cognitive functions. However, it is unclear which type of PA intervention is the most effective in children and adolescents with Neurodevelopmental Disorders (NDDs). This study aimed to compare the effectiveness of different types of PA interventions on cognitive functions in children and adolescents with NDDs, with additional analyses examining intervention effects across specific NDD types including attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
Methods
In this systematic review and network meta-analysis, seven databases (Web of Science, PubMed, Medline, APA PsycINFO, Embase, CINAHL, and SPORTDiscus) for randomized controlled trials from database inception to September 2023 were searched. Randomized controlled trials comparing the effectiveness of PA intervention with any non-pharmacological treatment or control group on cognitive functions in children and adolescents diagnosed with NDDs aged 5-17 years were included. Frequentist network meta-analyses were performed based on standardized mean differences (SMD) using random effects models to examine post-intervention differences in cognitive functions, including attention, memory, and executive functions. Intervention dropout was assessed as a measure of treatment acceptability.
Results
Thirty-one randomized controlled trials (n = 1,403, mean age 10.0 ± 1.9 years) with 66 arms were included in the network. Mind-body exercise (MBE; SMD = 1.91 for attention; 0.92 for executive functions), exergaming (SMD = 1.58 for attention; 0.97 for memory; 0.94 for executive functions), and multi-component physical activity (MPA; SMD = 0.79 for executive functions) were associated with moderate to substantial cognitive improvements compared with usual care, whereas the effectiveness of aerobic exercise (AE) was non-significant. Exergaming (SMD = 0.78, 95%CI 0.12 to 1.45) and MPA (SMD = 0.64, 95%CI 0.11 to 1.18) were more effective than AE for executive functions. When analyzing specific NDD types, exergaming lost its superiority over usual care for attention and memory in ADHD, nor for executive functions in ASD. Instead, MPA demonstrated significant benefits across these domains and populations. The certainty of evidence for these comparisons was very low to low. No significant differences in acceptability were observed among MBE, exergaming, and MPA.
Conclusions
The findings in this study suggest that MBE, exergaming, and MPA were effective interventions for improving domain-specific cognitive functions in children and adolescents with NDDs. AE demonstrated non-significant effectiveness for all outcomes. MBE emerges as particularly advantageous for attention. MPA yielded consistent improvements in memory and executive functions across NDD types. Further high-quality randomized controlled trials of direct comparisons are needed to confirm and expand on the findings from this NMA.
Trial registration
PROSPERO CRD42023409606.
Sources & attribution
Comparative effectiveness of physical activity interventions on cognitive functions in children and adolescents with Neurodevelopmental Disorders: a systematic review and network meta-analysis of randomized controlled trials.
Tao R, Yang Y, Wilson M, Chang JR, Liu C, Sit CHP.
The international journal of behavioral nutrition and physical activity · 2025-01-13
DOI: 10.1186/s12966-024-01702-7 ↗PubMed · 39806448 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

